STLN
Starling Oncology, Inc.
+0.33 (+5.05%)6.86USD1.1M成交股數699M市值–本益比(近四季)1.2股價營收比+34.6%營收年增(近四季)2026-11-09下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 4 · 351K · 1 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 2.1M · 2 |
| 其中 10b5-1 計畫賣出 | 3 筆 |
| 近 180 天 買進 · 賣出金額 | 1.4M · 2.6M |
| 近 180 天 淨額 | −1.2M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-21 | 08-24 | Hively Brad | Director | S 公開市場賣出(10b5-1) | 299K | 6.51 | 1.9M | 412K | SEC |
| 2026-08-14 | 08-17 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 12.0K | 6.54 | 78K | 10.7M | SEC |
| 2026-07-27 | 07-29 | Hively Brad | Director | A 獲配股票 | 27.1K | – | – | 711K | SEC |
| 2026-07-27 | 07-29 | TZOUMAKAS KIMBERLY JO | Director | A 獲配股票 | 29.1K | – | – | 46.3K | SEC |
| 2026-07-27 | 07-29 | Pacala Mark L | Director | A 獲配股票 | 30.1K | – | – | 287K | SEC |
| 2026-07-27 | 07-29 | McGeorge Anne | Director | A 獲配股票 | 41.2K | – | – | 333K | SEC |
| 2026-07-27 | 07-29 | STOLPER MARK | Director | A 獲配股票 | 31.1K | – | – | 57.0K | SEC |
| 2026-07-27 | 07-29 | Kaushal Mohit | Director | A 獲配股票 | 33.1K | – | – | 206K | SEC |
| 2026-07-27 | 07-29 | Johnson Karen Marie | Director | A 獲配股票 | 31.1K | – | – | 319K | SEC |
| 2026-07-21 | 07-22 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 18.0K | 5.27 | 95K | 10.6M | SEC |
| 2026-07-14 | 07-16 | Podnos Yale | Chief Medical Officer | S 公開市場賣出(10b5-1) | 18.0K | 6.43 | 116K | 260K | SEC |
| 2026-07-14 | 07-16 | Podnos Yale | Chief Medical Officer | M 選擇權執行 | 5.5K | 2.00 | 11K | 265K | SEC |
| 2026-07-14 | 07-16 | Podnos Yale | Chief Medical Officer | M 選擇權執行 | 18.0K | 1.87 | 34K | 278K | SEC |
| 2026-07-14 | 07-16 | Podnos Yale | Chief Medical Officer | S 公開市場賣出(10b5-1) | 5.5K | 6.35 | 35K | 260K | SEC |
| 2026-07-10 | 07-13 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 15.0K | 5.85 | 88K | 10.6M | SEC |
| 2026-07-07 | 07-09 | TZOUMAKAS KIMBERLY JO | Director | A 獲配股票 | 17.2K | – | – | 17.2K | SEC |
| 2026-07-07 | 07-09 | STOLPER MARK | Director | A 獲配股票 | 25.8K | – | – | 25.8K | SEC |
| 2026-06-23 | 06-24 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 18.0K | 5.02 | 90K | 10.6M | SEC |
| 2026-06-08 | 06-09 | Podnos Yale | Chief Medical Officer | S 公開市場賣出(10b5-1) | 23.5K | 5.38 | 126K | 260K | SEC |
| 2026-06-04 | 06-05 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 12.0K | 4.75 | 57K | 10.6M | SEC |
| 2026-05-21 | 05-22 | Carter Robert Ross | Chief Financial Officer | J 其他 | 1.6K | 4.47 | 7K | 415K | SEC |
| 2026-05-21 | 05-22 | Podnos Yale | Chief Medical Officer | J 其他 | 1.8K | 4.47 | 8K | 283K | SEC |
| 2026-05-21 | 05-22 | Virnich Daniel | Chief Executive Officer | J 其他 | 23.1K | 4.47 | 103K | 2.3M | SEC |
| 2026-05-20 | 05-21 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 33.5K | 4.07 | 136K | 10.6M | SEC |
| 2026-05-19 | 05-21 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 5.0K | 4.05 | 20K | 10.5M | SEC |
| 2026-05-19 | 05-20 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 30.0K | 4.09 | 123K | 10.5M | SEC |
| 2026-04-16 | 04-16 | Kaushal Mohit | Director | S 公開市場賣出(10b5-1) | 38.4K | 3.50 | 135K | 173K | SEC |
| 2026-04-14 | 04-16 | Kaushal Mohit | Director | S 公開市場賣出(10b5-1) | 57.3K | 3.50 | 201K | 211K | SEC |
| 2026-04-09 | 04-13 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 20.0K | 3.10 | 62K | 10.5M | SEC |
| 2026-03-27 | 04-01 | Virnich Daniel | Chief Executive Officer | J 其他 | 98.5K | 3.07 | 302K | 2.4M | SEC |
| 2026-03-27 | 04-01 | England Kristin | Chief Administrative Officer | A 獲配股票 | 55.7K | – | – | 154K | SEC |
| 2026-03-27 | 04-01 | Virnich Daniel | Chief Executive Officer | A 獲配股票 | 671K | – | – | 2.5M | SEC |
| 2026-03-27 | 04-01 | Carter Robert Ross | Chief Financial Officer | A 獲配股票 | 203K | – | – | 437K | SEC |
| 2026-03-27 | 04-01 | Podnos Yale | Chief Medical Officer | J 其他 | 16.2K | 3.07 | 50K | 285K | SEC |
| 2026-03-27 | 04-01 | Langsam Jeffrey | Chief Clinical Officer | A 獲配股票 | 70.3K | – | – | 128K | SEC |
| 2026-03-27 | 04-01 | Carter Robert Ross | Chief Financial Officer | J 其他 | 20.3K | 3.07 | 62K | 416K | SEC |
| 2026-03-27 | 04-01 | Podnos Yale | Chief Medical Officer | A 獲配股票 | 66.4K | – | – | 301K | SEC |
| 2026-03-27 | 03-30 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 27.4K | 2.96 | 81K | 10.5M | SEC |
| 2026-03-26 | 03-27 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 50.0K | 3.15 | 158K | 10.5M | SEC |
| 2026-03-24 | 03-25 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 125K | 3.11 | 389K | 10.4M | SEC |
| 2026-03-20 | 03-23 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 25.0K | 3.35 | 84K | 10.3M | SEC |
| 2026-03-17 | 03-18 | Carter Robert Ross | Chief Financial Officer | J 其他 | 1.3K | 3.59 | 5K | 234K | SEC |
| 2026-03-17 | 03-18 | Podnos Yale | Chief Medical Officer | J 其他 | 3.4K | 3.59 | 12K | 235K | SEC |
| 2026-03-17 | 03-18 | Virnich Daniel | Chief Executive Officer | J 其他 | 11.8K | 3.59 | 42K | 1.8M | SEC |
| 2026-03-17 | 03-17 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 75.0K | 3.42 | 257K | 10.3M | SEC |
| 2026-03-16 | 03-17 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 61.0K | 3.29 | 201K | 10.2M | SEC |
| 2026-03-13 | 03-17 | Chernett Jorey | TenPercentOwner | P 公開市場買進 | 263K | 2.92 | 768K | 10.1M | SEC |
| 2026-01-02 | 01-06 | Carter Robert Ross | Chief Financial Officer | J 其他 | 244 | 3.67 | 895.48 | 235K | SEC |
| 2026-01-02 | 01-05 | Carter Robert Ross | Chief Financial Officer | S 公開市場賣出 | 247 | 3.56 | 879.32 | 235K | SEC |
| 2025-12-15 | 12-16 | Hively Brad | Director | S 公開市場賣出 | 13.3K | 3.77 | 50K | 684K | SEC |
| 2025-11-20 | 11-24 | Kaushal Mohit | Director | A 獲配股票 | 40.1K | – | – | 268K | SEC |
| 2025-11-20 | 11-24 | McGeorge Anne | Director | A 獲配股票 | 67.9K | – | – | 251K | SEC |
| 2025-11-20 | 11-24 | Johnson Karen Marie | Director | A 獲配股票 | 37.0K | – | – | 288K | SEC |
| 2025-11-20 | 11-24 | Ling Gabriel | Director | A 獲配股票 | 37.0K | – | – | 334K | SEC |
| 2025-11-20 | 11-24 | Ling Gabriel | Director | A 獲配股票 | 46.3K | – | – | 297K | SEC |
| 2025-11-20 | 11-24 | Hively Brad | Director | A 獲配股票 | 32.4K | – | – | 697K | SEC |
| 2025-11-20 | 11-24 | Johnson Karen Marie | Director | A 獲配股票 | 47.8K | – | – | 251K | SEC |
| 2025-11-20 | 11-24 | Kaushal Mohit | Director | A 獲配股票 | 50.9K | – | – | 228K | SEC |
| 2025-11-20 | 11-24 | Pacala Mark L | Director | A 獲配股票 | 35.5K | – | – | 257K | SEC |
| 2025-11-20 | 11-24 | Pacala Mark L | Director | A 獲配股票 | 46.3K | – | – | 221K | SEC |
| 2025-11-20 | 11-24 | Hively Brad | Director | A 獲配股票 | 41.7K | – | – | 665K | SEC |
| 2025-11-20 | 11-24 | McGeorge Anne | Director | A 獲配股票 | 40.1K | – | – | 291K | SEC |
| 2025-11-18 | 11-20 | Pacala Mark L | Director | S 公開市場賣出 | 1.2K | 4.00 | 5K | 222K | SEC |
| 2025-11-18 | 11-20 | M33 Growth I GP LLC | Director | J 其他 | 591K | – | – | 0 | SEC |
| 2025-11-18 | 11-20 | Pacala Mark L | Director | S 公開市場賣出 | 2.2K | 4.00 | 9K | 223K | SEC |
| 2025-11-18 | 11-20 | Ling Gabriel | Director | J 其他 | 141K | – | – | 250K | SEC |
| 2025-11-18 | 11-20 | M33 Growth I GP LLC | Director | J 其他 | 2.5M | – | – | 5.4M | SEC |
| 2025-11-18 | 11-20 | M33 Growth I GP LLC | Director | J 其他 | 11.8K | – | – | 7.9M | SEC |
| 2025-11-18 | 11-20 | TOI M, LLC | Director | J 其他 | 2.5M | – | – | 5.4M | SEC |
| 2025-11-18 | 11-20 | TOI M, LLC | Director | J 其他 | 11.8K | – | – | 7.9M | SEC |
| 2025-11-18 | 11-20 | TOI M, LLC | Director | J 其他 | 591K | – | – | 0 | SEC |
| 2025-11-18 | 11-20 | M33 Growth I L.P. | Director | J 其他 | 2.5M | – | – | 5.4M | SEC |
| 2025-11-18 | 11-20 | M33 Growth I L.P. | Director | J 其他 | 11.8K | – | – | 7.9M | SEC |
| 2025-11-18 | 11-20 | M33 Growth I L.P. | Director | J 其他 | 591K | – | – | 0 | SEC |
| 2025-11-18 | 11-20 | Pacala Mark L | Director | S 公開市場賣出 | 46.6K | 4.00 | 187K | 175K | SEC |
| 2025-11-17 | 11-19 | Carter Robert Ross | Chief Financial Officer | A 獲配股票 | 195 | – | – | 235K | SEC |
| 2025-11-17 | 11-19 | Virnich Daniel | Chief Executive Officer | A 獲配股票 | 6.5K | – | – | 1.8M | SEC |
| 2025-11-17 | 11-19 | Podnos Yale | Chief Medical Officer | A 獲配股票 | 2.1K | – | – | 238K | SEC |
| 2025-11-12 | 11-14 | Podnos Yale | Chief Medical Officer | A 獲配股票 | 1.2K | – | – | 236K | SEC |
| 2025-11-12 | 11-14 | Podnos Yale | Chief Medical Officer | A 獲配股票 | 306 | – | – | 235K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 ·
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| 沒有 13F 資料。 | ||||
持有機構數近 12 季
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
最新一期
| 空單股數 | 6.8M |
|---|---|
| 與上期比 | -1.0% |
| 佔流通股數 | 6.69% |
| 日均成交量 | 1.2M |
| 回補天數 | 5.6 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.8M | -1.0% | 6.69% | 1.2M | 5.6 |
| 2026-08-14 | 6.9M | -3.8% | 6.75% | 2.0M | 3.5 |